Workshop
PTAC/CFTR
1. Suppression of CFTR Nonsense Mutations by Distinct Classes of Small Molecule Readthrough Agents – Presented by David Bedwell
2. Specific Potentiation of the TMEM16A Chloride Channel Can Rescue Impaired Mucociliary Transport in Human Airway Models of Cystic Fibrosis – Presented by Peihang Li
3. A Novel Gamma-Secretase Inhibitor Reprograms Maladaptive Cystic Fibrosis Airway Epithelia and Restores Mucociliary Clearance – Presented by Marcos Milla
4. SPL23, an Exon-Skipping Antisense Oligonucleotide for PwCF Carrying the W1282X Variant – Presented by Efrat Ozeri-Galai
5. A Randomized 28-Day, Double-Blind Cross-Over Study to Evaluate the Safety, Efficacy & Pharmacokinetics of ETD001, an Inhaled ENaC Blocker, in People with Cystic Fibrosis – Presented by Marcus A. Mall
Henry Danahay
Enterprise Therapeutics
Dan Devor, PhD
Univ of Pittsburgh
David M. Bedwell, PhD
University of Alabama at Birmingham
Peihang Li
Washington University in St. Louis
Marcos E. Milla, PhD
Alentar Biosciences
Efrat Ozeri-Galai
SpliSense
Marcus A. Mall, MD
Charité–Universitätsmedizin Berlin